Marico Hikes PLIX Stake to 84%, Sees Q2 Profit Growth

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorAarav Shah|Published at:
Marico Hikes PLIX Stake to 84%, Sees Q2 Profit Growth

FMCG major Marico has increased its stake in Satiya Nutraceuticals, the parent of wellness brand PLIX, to 84.09% for ₹1,012 crore. Alongside this expansion, the company announced a positive Q2 FY27 outlook, projecting double-digit revenue growth and mid-twenties operating profit growth. The market responded positively to the update, with the stock trading higher.

Marico Limited has officially increased its stake in Satiya Nutraceuticals, the parent company of the health and wellness brand PLIX, to 84.09% on a fully diluted basis. The company invested ₹1,012.03 crore for this additional 24.09% holding. Following the announcement, Marico shares saw a positive reaction in the market, trading higher by 1.35% to 3% during the session.

This acquisition marks a significant step in Marico’s effort to move beyond its traditional dominance in staples like hair oil and edible oils. By integrating PLIX, the company is positioning itself to capture a larger share of the fast-growing health and wellness market, which appeals to younger, digital-savvy consumers. The company has structured the deal with an option to acquire the remaining 14.09% stake by July 2027, ensuring a phased approach to full ownership and brand control.

In a parallel update for the second quarter of the 2027 financial year, Marico shared a robust performance outlook. The FMCG giant expects to report double-digit growth in consolidated revenue and mid-twenties growth in operating profit. This optimism is driven by strong domestic demand, with the India business achieving double-digit underlying volume growth. Notably, its flagship Parachute Coconut Oil continues to perform well, with volume growth in the early teens, while Saffola Oil has maintained steady growth.

While the outlook is positive, investors may track how Marico integrates these digital-first brands into its traditional, massive distribution network. The business model for specialized wellness products can differ from high-volume staples, potentially creating execution challenges as the company scales. Additionally, the firm remains exposed to commodity price volatility, particularly for crude-linked raw materials, which can impact profit margins if costs spike unexpectedly.

The next important monitorable for shareholders will be the company’s ability to sustain this volume growth across its core brands while managing the integration of new business verticals. Investors will also look for updates on the timeline for acquiring the final tranche of shares by July 2027, which remains a key milestone in this long-term investment strategy.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.